BR0015270A - Método e composições para tratamento de doenças pulmonares - Google Patents

Método e composições para tratamento de doenças pulmonares

Info

Publication number
BR0015270A
BR0015270A BR0015270-6A BR0015270A BR0015270A BR 0015270 A BR0015270 A BR 0015270A BR 0015270 A BR0015270 A BR 0015270A BR 0015270 A BR0015270 A BR 0015270A
Authority
BR
Brazil
Prior art keywords
compositions
lung diseases
treating lung
diseases
treating
Prior art date
Application number
BR0015270-6A
Other languages
English (en)
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR0015270A publication Critical patent/BR0015270A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO E COMPOSIçõES PARA TRATAMENTO DE DOENçAS PULMONARES". Esta invenção se refere ao tratamento de doenças pulmonares, tais como doença pulmonar obstrutiva ou asma, por administração de um inibidor de fosfodiesterase 4 em combinação com corticosteróide antiinflamatório.
BR0015270-6A 1999-11-02 2000-11-01 Método e composições para tratamento de doenças pulmonares BR0015270A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
BR0015270A true BR0015270A (pt) 2002-06-18

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015270-6A BR0015270A (pt) 1999-11-02 2000-11-01 Método e composições para tratamento de doenças pulmonares

Country Status (29)

Country Link
EP (1) EP1225866A4 (pt)
JP (1) JP2003513028A (pt)
KR (1) KR20020057988A (pt)
CN (1) CN1387404A (pt)
AP (1) AP2002002496A0 (pt)
AR (1) AR029189A1 (pt)
AU (1) AU1357501A (pt)
BG (1) BG106748A (pt)
BR (1) BR0015270A (pt)
CA (1) CA2388333A1 (pt)
CO (1) CO5261512A1 (pt)
CZ (1) CZ20021512A3 (pt)
DZ (1) DZ3225A1 (pt)
EA (1) EA200200518A1 (pt)
EC (1) ECSP003747A (pt)
HK (1) HK1049107A1 (pt)
HU (1) HUP0203152A3 (pt)
IL (1) IL149367A0 (pt)
MA (1) MA26841A1 (pt)
MX (1) MXPA02004350A (pt)
NO (1) NO20022057L (pt)
OA (1) OA12076A (pt)
PE (1) PE20011005A1 (pt)
PL (1) PL355261A1 (pt)
SK (1) SK7592002A3 (pt)
TR (1) TR200201211T2 (pt)
TW (1) TWI242431B (pt)
WO (1) WO2001032127A2 (pt)
ZA (1) ZA200203435B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242597A1 (en) * 2001-09-19 2004-12-02 Thomas Klein Combination
JP2005515975A (ja) * 2001-10-31 2005-06-02 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ４型ホスホジエステラーゼ阻害剤およびこれらの使用
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US20060199789A1 (en) * 2003-03-31 2006-09-07 Kyowa Hakko Kogyo Co., Ltd. medical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1466598A3 (en) * 1993-06-18 2007-06-27 Smithkline Beecham Corporation PDE-IV inhibitors
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
NO20022057L (no) 2002-06-27
OA12076A (en) 2006-05-04
NO20022057D0 (no) 2002-04-30
WO2001032127A2 (en) 2001-05-10
PL355261A1 (en) 2004-04-05
CZ20021512A3 (cs) 2003-04-16
ZA200203435B (en) 2003-06-25
IL149367A0 (en) 2002-11-10
BG106748A (en) 2003-02-28
PE20011005A1 (es) 2001-09-28
ECSP003747A (es) 2002-05-23
SK7592002A3 (en) 2002-11-06
EP1225866A2 (en) 2002-07-31
AU1357501A (en) 2001-05-14
CO5261512A1 (es) 2003-03-31
CA2388333A1 (en) 2001-05-10
HUP0203152A2 (hu) 2003-01-28
HUP0203152A3 (en) 2004-06-28
CN1387404A (zh) 2002-12-25
MXPA02004350A (es) 2002-11-07
KR20020057988A (ko) 2002-07-12
JP2003513028A (ja) 2003-04-08
TWI242431B (en) 2005-11-01
EP1225866A4 (en) 2004-04-21
AR029189A1 (es) 2003-06-18
EA200200518A1 (ru) 2002-10-31
AP2002002496A0 (en) 2002-06-30
HK1049107A1 (zh) 2003-05-02
WO2001032127A3 (en) 2001-12-06
DZ3225A1 (fr) 2001-05-10
MA26841A1 (fr) 2004-12-20
TR200201211T2 (tr) 2002-08-21

Similar Documents

Publication Publication Date Title
BR9913152A (pt) Terapias para tratamento de doenças pulmonares
BR0211450A (pt) Método terapêutico
WO2003000241A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika; corticosteroiden und betamimetika zur behandlung von entzündlichen und/oder obstruktiven atemwegserkrankungen
WO2001042231A3 (en) Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
EP1140840A4 (en) DIPHENYLUREA WITH SUBSTITUENTS -G (V) -CARBOXYARYLES, INHIBITORS OF RAF KINASE
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
BR9712314A (pt) Método de uso de inibidores de ciclooxigenase-2 no tratamento e prevenção de neoplasia
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
BR9911666A (pt) Combinação farmacêutica, uso da combinação, processo para tratamento de uma doença inflamatória em uma pessoa sofrendo de ou susceptìvel a tal doença, e, composição farmacêutica
BR0009446A (pt) Composto, processo para preparar o mesmo, composição uso de um composto, e, métodos para o tratamento ou a prevenção de uma doença em um mamìfero, para o tratamento ou a prevenção de asma em um mamìfero e para o tratamento ou a prevenção de doença pulmonar obstrutiva crÈnica em um mamìfero
BRPI0511424A (pt) composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para a preparação de um composto
WO2001096298A3 (en) 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
BR0015270A (pt) Método e composições para tratamento de doenças pulmonares
WO2003072593A3 (en) Bone targeting peptides
BR9812062A (pt) Composto, uso deste, processo para prepará-lo, enanciÈmero único purificado, composição farmacêutica, e, processos para tratamento de bronquite crÈnica ou de doença pulmonar obstrutiva crÈnica em um indivìduo humano ou animal, e para tratamento de asma em um indivìduo humano ou animal
BR0213037A (pt) Derivados de pirimidina
BR0010546A (pt) Terapia antiinflamatória para infecção mediada inflamatória
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
BR0008382A (pt) Formulação de liberação controlada para tratamento de copd

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.